
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
| Open | 3,262.60 |
| High | 3,264.00 |
| Low | 3,170.20 |
| Prev Close | 3,246.20 |
| Volume | 2,06,986 |
| VWAP(₹) | 3,212.64 |
| PE Ratio(x) | 74.68 |
| EPS - TTM(₹) | 43.51 |
| MCap(₹ Cr.) | 26,604.84 |
| MCap Rank | 6 |
| PB Ratio(x) | 15.54 |
| Div Yield(%) | - |
| Face Value(₹) | 5.00 |
| 52W High(₹) | 3,444.30 |
| 52W Low(₹) | 1,059.00 |
| MCap/Sales | 15.64 |
| Beta(1 Month) | - |
| BV/Share(₹) | 208.96 |
ROE Outperforming 5 Year Average
Company delivered ROE of 21.54% in year ending Mar 31, 2026 outperforming its 5 year avg. of 15.0%. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 8.78% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)Ami Organics Share Price Update
Acutaas Chemicals Ltd. share price moved up by 0.11% from its previous close of Rs 3,246.20. Acutaas Chemicals Ltd. stock last traded price is 3,249.60
| Share Price | Value |
|---|---|
| Today/Current/Last | 3,249.60 |
| Previous Day | 3,246.20 |
Found Insights useful?
| 1 Day | 0.11% |
| 1 Month | 10.11% |
| 3 Months | 35.41% |
| 1 Year | 187.02% |
| 3 Years | 408.13% |
| 5 Years | N.A. |
8 Analysts
| Ratings | Current | 1W Ago | 1M Ago | 3M Ago |
|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 |
| Hold | - | - | - | - |
| Sell | - | - | 1 | 1 |
| Strong Sell | 1 | 1 | - | - |
| # Analysts | 8 | 8 | 8 | 8 |
Forget the noise: These 54 smallcap stocks attracted FII buying in March quarter
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requir..
AnnouncementsAnnouncement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
AnnouncementsAnnouncement under Regulation 30 (LODR)-Cessation
Announcements| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | |
|---|---|---|---|---|---|
| Total Income | 443.86 | 397.88 | 316.03 | 223.17 | 314.26 |
| Total Income Growth (%) | 11.56 | 25.90 | 41.61 | -28.98 | 13.59 |
| Total Expenses | 258.87 | 252.35 | 219.27 | 164.46 | 230.82 |
| Total Expenses Growth (%) | 2.58 | 15.09 | 33.33 | -28.75 | 8.55 |
| EBIT | 184.99 | 145.53 | 96.76 | 58.71 | 83.44 |
| EBIT Growth (%) | 27.12 | 50.41 | 64.80 | -29.63 | 30.33 |
| Profit after Tax (PAT) | 131.76 | 107.96 | 72.24 | 44.29 | 62.48 |
| PAT Growth (%) | 22.05 | 49.45 | 63.10 | -29.11 | 38.99 |
| EBIT Margin (%) | 41.68 | 36.58 | 30.62 | 26.31 | 26.55 |
| Net Profit Margin (%) | 29.69 | 27.13 | 22.86 | 19.85 | 19.88 |
| Basic EPS (₹) | 16.09 | 13.19 | 8.82 | 5.41 | 7.80 |
All figures in Rs Cr, unless mentioned otherwise
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 8.78% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Total Assets | 1,983.96 | 1,549.26 | 1,095.90 | 766.94 | 658.88 |
| Total Assets Growth (%) | 28.06 | 41.37 | 42.89 | 16.40 | 59.43 |
| Total Liabilities | 273.21 | 229.18 | 413.15 | 172.98 | 136.61 |
| Total Liabilities Growth (%) | 19.21 | -44.53 | 138.84 | 26.62 | -44.54 |
| Total Equity | 1,710.75 | 1,320.08 | 682.76 | 593.96 | 522.27 |
| Total Equity Growth (%) | 29.59 | 93.35 | 14.95 | 13.73 | 212.86 |
| Current Ratio (x) | 3.82 | 3.91 | 1.74 | 2.89 | 3.32 |
| Total Debt to Equity (x) | 0.02 | 0.01 | 0.32 | 0.01 | 0.00 |
| Contingent Liabilities | 0.00 | 95.65 | 96.99 | 2.70 | 2.70 |
All figures in Rs Cr, unless mentioned otherwise
| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Net Cash flow from Operating Activities | 292.17 | 118.34 | 125.17 | 65.53 | -8.66 |
| Net Cash used in Investing Activities | -265.94 | -223.94 | -365.39 | -33.04 | -123.99 |
| Net Cash flow from Financing Activities | 4.10 | 261.12 | 239.36 | -12.25 | 140.26 |
| Net Cash Flow | 30.33 | 155.52 | -0.83 | 20.24 | 7.61 |
| Closing Cash & Cash Equivalent | 215.55 | 185.22 | 29.70 | 30.53 | 10.30 |
| Closing Cash & Cash Equivalent Growth (%) | 16.37 | 523.56 | -2.71 | 196.53 | 283.49 |
| Total Debt/ CFO (x) | 0.09 | 0.07 | 1.73 | 0.05 | -0.10 |
All figures in Rs Cr, unless mentioned otherwise
Increase in Cash from Investing
Company has used Rs 265.94 cr for investing activities which is an YoY increase of 18.75%. (Source: Consolidated Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Return on Equity (%) | 21.54 | 12.11 | 6.34 | 14.02 | 13.77 |
| Return on Capital Employed (%) | 27.72 | 16.50 | 14.79 | 18.96 | 18.47 |
| Return on Assets (%) | 17.95 | 10.24 | 3.90 | 10.86 | 10.91 |
| Interest Coverage Ratio (x) | 159.72 | 40.04 | 22.89 | 52.62 | 16.85 |
| Asset Turnover Ratio (x) | 0.76 | 0.76 | 0.77 | 0.87 | 0.97 |
| Price to Earnings (x) | 58.82 | 63.29 | 95.24 | 38.91 | 50.76 |
| Price to Book (x) | 12.67 | 7.63 | 5.99 | 5.45 | 6.97 |
| EV/EBITDA (x) | 39.85 | 39.21 | 30.95 | 25.09 | 32.83 |
| EBITDA Margin (%) | 38.97 | 24.73 | 18.95 | 20.58 | 20.75 |
ROE Outperforming 5 Year Average
Company delivered ROE of 21.54% in year ending Mar 31, 2026 outperforming its 5 year avg. of 15.0%. (Source: Consolidated Financials)Found Financials useful?
No Data Available
No Data Available
| R1 | - | Pivot - | S1 | - |
| R2 | - | S2 | - | |
| R3 | - | S3 | - |
| 5 Days | 14 Days | 28 Days |
| - | - | - |
Choose from Peers
Choose from Stocks
MF Ownership as on 31 May 2026
459.27
Amount Invested (in Cr.)
1.74963297%
% of AUM
0.00
% Change (MoM basis)
281.93
Amount Invested (in Cr.)
6.17%
% of AUM
0.00
% Change (MoM basis)
197.35
Amount Invested (in Cr.)
0.50057127%
% of AUM
0.00
% Change (MoM basis)
Final
50%
Apr 30, 2026
Board Meeting
Audited Results & Final Dividend
Apr 27, 2026
Board Meeting
Quarterly Results
Jan 21, 2026
| Announced on | Meeting on |
| Apr 27, 2026 | Apr 30, 2026 |
| Audited Results & Final Dividend | |
| Jan 21, 2026 | Jan 28, 2026 |
| Quarterly Results | |
| Oct 10, 2025 | Oct 17, 2025 |
| Quarterly Results | |
| Jul 24, 2025 | Jul 30, 2025 |
| Quarterly Results | |
| Apr 24, 2025 | May 02, 2025 |
| Audited Results & Final Dividend | |
| Announced on | Ex-Date | Dividend% |
| May 02, 2025 | Sep 18, 2025 | 30% |
| May 10, 2024 | Sep 13, 2024 | 30% |
| May 15, 2023 | Sep 18, 2023 | 30% |
| May 16, 2022 | Jul 29, 2022 | 30% |
| Apr 30, 2026 | - | 50% |
No Data Available
| Announced on | Ex-Date |
| Feb 21, 2025 | Apr 25, 2025 |
| Split: Old FV10.0| New FV:5.0 | |
No Data Available
| Announced on | Meeting on |
| Sep 02, 2025 | Sep 25, 2025 |
| - | |
| Apr 17, 2025 | May 10, 2025 |
| - | |
| Feb 24, 2025 | Mar 28, 2025 |
| - | |
| Sep 02, 2024 | Sep 20, 2024 |
| A.G.M. | |
| Sep 05, 2023 | Sep 25, 2023 |
| A.G.M. | |
Acutaas Chemicals Ltd., incorporated in the year 2007, is a Small Cap company (having a market cap of Rs 26,604.84 Crore) operating in Chemicals sector.
Industry
Key Indices Listed On
BSE 500, BSE 250 SmallCap Index, BSE SmallCap, BSE Healthcare, BSE 400 MidSmallCap Index
Address
Plot No. 440/4, 5 & 6,Road No. 82/A,Surat, Gujarat - 394230
Nareshkumar Ramjibhai Patel
Exe.Chairman & Mng.DirectorChetankumar Chhaganlal Vaghasia
Whole Time DirectorRam Mohan Rao Locande
Whole Time DirectorVirendra Nath Mishra
Whole Time DirectorDATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.